Microbix Biosystems Inc. provided earnings guidance for the fiscal year 2022. For the year, the company excepts that fiscal 2022 will realize materially-positive net earnings, as were achieved in fiscal 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 CAD | -1.54% | -3.03% | -17.95% |
05-15 | Microbix Biosystems Up More Than 10% As Q2 Profit Grows On Higher Revenues; Says Stage Set For Record FY | MT |
05-15 | Transcript : Microbix Biosystems Inc., Q2 2024 Earnings Call, May 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.95% | 32.07M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- MBX Stock
- News Microbix Biosystems Inc.
- Microbix Biosystems Inc. Provides Earnings Guidance for the Fiscal Year 2022